HEALEY ALS Platform Trial Q&A Webinar

Please join us on Thursday, March 17th at 5:00 pm EST (4:00pm CST/2:00pm PST) for a webinar about the HEALEY ALS Platform Trial and a special introduction to the study team at the University of Kentucky. Sabrina Paganoni, MD, PhD and Merit Cudkowicz, MD, MSc will present this week’s updates on the HEALEY ALS Platform Trial and answer questions from the audience. In addition, we will be joined by Edward J. Kasarskis, MD, PhD, the Platform Trial Site Investigator at the University of Kentucky in Lexington, KY.

Edward J. Kasarskis, MD, PhD
Dr. Ed Kasarskis has dedicated his entire medical career to researching ALS, commonly known as Lou Gehrig’s disease. There is no known cure for ALS, but Dr. Kasarskis hopes that his work and that of his team will lead to breakthroughs that are broadly applicable—both in ALS and in related conditions like Parkinson’s, Alzheimer’s or dementia